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Abstract Early diagnosis of Turner syndrome (TS) is necessary
to facilitate appropriate management, including growth promo-
tion.Not all girls with TS have overt short stature, and comparison
with parental height (Ht) is needed for appropriate evaluation.We
examined both the prevalence and diagnostic sensitivity of mea-
sured parental Ht in a dedicated TS clinic between 1989 and 2013.
Lower end of parental target range (LTR) was calculated as mid-
parental Ht (correction factor 12.5 cmminus 8.5 cm) and convert-
ed to standard deviation scores (SDS) using UK 1990 data, then
compared with patient Ht SDS at first accurate measurement aged
> 1 year. Information was available in 172 girls of whom 142
(82.6%) were short at first measurement. However, both parents
had been measured in only 94 girls (54.6%). In 92 of these girls
age at measurement was 6.93 ± 3.9 years, Ht SDS vs LTRSDS−
2.63 ± 0.94 vs − 1.77 ± 0.81 (p< 0.001), Ht SDS<LTR in 78/92
(85%). Eleven of the remaining 14 girls were < 5 years, while
karyotype was 45,X/46,XX in 2 and 45,X/47,XXX in 3.
Conclusion: This study confirms the sensitivity of evaluat-
ing height status against parental height but shows that the
latter is not being consistently measured.
What is Known:
• Girls with Turner syndrome are short in relation to parental heights,
with untreated final height approximately 20 cm below female
population mean.
• Measured parental height is more accurate than reported height.
What is New:
• In a dedicated Turner clinic, there was 85% sensitivity when comparing
patient height standard deviation score at first accurate measurement
beyond 1 year of age with the lower end of the parental target range
standard deviation.
• However, measured height in both parents had been recorded in
only 54.6% of the Turner girls attending the clinic. This
indicates the need to improve the quality of growth assessment
in tertiary care.
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Introduction
Short stature, defined as height below the 2.5th centile or more
than two standard deviation scores (SDS) below the mean for
a given population, is the commonest cause of referral to the
endocrine clinic. The physician’s challenge is to accurately
diagnose the relatively small proportion of short children with
pathology by the most economic means possible, while spar-
ing unnecessary investigation in the majority of naturally short
children.
An important cause of short stature in girls is Turner syn-
drome, defined as loss of one sex chromosome or abnormality
of the secondX chromosome in at least one major cell line in a
phenotypic female [3]. Short stature is a cardinal feature of
Turner syndrome, untreated girls reaching final heights some
20 cm below the mean female height for the population con-
cerned [11]. Early diagnosis is desirable partly because the
short stature of Turner syndrome is amenable to treatment
with growth-promoting therapy [15] but also because of the
important implications for pubertal development and future
fertility. Furthermore, late cardiovascular complications such
as aortic dissection may be prevented when associated cardio-
vascular disorders such as aortic coarctation, bicuspid valve,
and hypertension are identified [18].
Diagnosis of Turner syndrome is straightforward if the
child presents with obvious dysmorphic features at birth such
as pedal oedema and neck webbing with or without cardiac
anomaly. However, girls presenting in childhood with short
stature may have only subtle phenotypic traits which can be
easily overlooked. It has been recommended that any girl who
presents with short stature and/or premature ovarian failure
should have a karyotype performed, in order to detect
Turner syndrome [9].While it is essential to request karyotype
in any girl with ovarian failure, the feasibility and cost effec-
tiveness of performing karyotype in all girls with short stature
is open to question. This is because stature screening is neither
specific nor wholly sensitive for Turner syndrome. In
Scotland, for example, there were 53,802 live births for the
year ending 31 March 2015 (http://www.nrscotland.gov.uk/
statistics-and-data/statistics/statistics-by-theme/vital-events/
general-publications/births-deaths-and-other-vital-events-
quarterly-figures/1st-quarter-2015) so that an estimated 800 of
the girls would be below the 3rd centile. Assuming a
prevalence of 1 in 2000 live female births for Turner
syndrome [8] it follows that only about 13 of the 800 short
girls would have the condition, giving a very low specificity
(1.6%) for crude short stature screening. Furthermore,
childhood height in Turner syndrome is influenced by
parental height [6] so that girls with tall parents may not be
frankly short, especially during the early years.
Saari and colleagues have highlighted the value of combin-
ing three criteria—growth rate, height for age, and height in
relation to parental height, in order to facilitate diagnosis of
Turner syndrome [12]. We have shown previously that report-
ed parental height is unreliable and that measured parental
heights should be sought wherever possible [2].
Given the potential value of parental height in growth as-
sessment, we wished to evaluate the quality of our growth
service by determining the number and percentage of patients
attending a dedicated Turner clinic in which height measure-
ment had been carried out in both parents as well as the fre-
quency of either only one or neither parent being measured.
We have also examined the sensitivity of measured parental
height in the diagnosis of Turner syndrome by comparing the
height (Ht) SDS at the time of first accurate measurement with
the Ht SDS of the lower end of the parental target range. Given
that most girls with Turner syndrome show a degree of intra-
uterine growth restriction [5], a secondary aim of this study
was to examine the sensitivity of the birth weight (BW) SDS
in relation to specified cut-offs.
Patients and methods
Patients
The case notes of all girls with Turner syndrome, proven on
karyotype, who had attended the Endocrine department at the
Royal Hospital for Sick Children in Glasgow between 1989
and 2013 were reviewed and data collected up to and includ-
ing 31 December 2014. The first height of each girl, after the
first year of life, which had been recorded by accurate mea-
surement using a stadiometer, and before any treatment with
growth hormone had been started, was noted. The height of
each girl’s mother and father was recorded as either measured,
reported or not known/not recorded. The karyotype of each
girl, analysed by cytogenetic analysis of lymphocyte culture
counting 50 cells, was noted. Additional information gathered
included birth weight and gestation, and associated disorders
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including cardiac malformations, gastrointestinal disorders
such as inflammatory bowel and coeliac disease, middle and
inner ear, endocrine, orthopaedic, and skin problems. Detail
on learning difficulties in the patient population was consid-
ered to be beyond the scope of the study.
Analysis of growth data
Mid-parental height (MPH) and parental target range were
calculated as previously described [10], modified from
Tanner’s system [16]. MPH was calculated as (mothers’
height + fathers’ height − 12.5 cm) ÷ 2. Lower end of parental
target range (LTR) was determined by taking 8.5 cm as two
standard deviations below MPH, i.e. MPH - 8.5 cm.
SDS values for the heights of the girls and parents were
calculated using UK 1990 growth data [4]. MPH and LTR
SDS were calculated for an adult age of 20 years, employing
the LMS software developed by Professor TimCole using UK
1990 data http://www.healthforallchildren.com/?product_cat=
software) [4]. BW SDS was calculated according to gestation
using the LMS software.
The number of girls with Ht SDS < − 2 was recorded, to
provide a measure of the sensitivity of short stature screening
in the diagnosis of Turner syndrome.
When both parents had been measured, girls’ Ht SDS was
compared with both LTR SDS and population height of − 2
SDS, in order to determine the prevalence of shortness relative
to parental heights and the general population, and hence the
sensitivity of family-specific shortness and short stature
screening.
This exercise of comparing girls’ Ht SDS with LTR SDS
was repeated for girls with available accurate first measure-
ment in whom either one measured or one reported parental
height; or both reported parental heights were documented.
The relationship between birth weight SDS, height at first
measurement after the age of 1 year, and the LTR was also
examined, taking BW SDS values < − 2 SDS, − 2 to < − 1.5
SDS and − 1.5 to < − 1.0 SDS, and examining the sensitivity
of these birthweight cut-offs in the detection of Turner
syndrome.
The data were analysed using Minitab statistical software
(Version 13.1). Normality of distribution was tested using the
Anderson-Darling method. If data were normally distributed,
ANOVAwas used for analysis and if non-parametrically dis-
tributed then Mann-Witney or Kruskall-Wallis and Mann-
Witney test were used. Confidence level was 95% and p values
were significant at < 0.05.
Ethical aspects
The data were held electronically on a password-protected
computer in the section of Child Health at the Royal
Hospital for Sick Children in Glasgow. The study was
registered with the Clinical Governance Support Unit of
NHS (National Health Service) Greater Glasgow and Clyde
as a quality improvement project.
Results
Between 1989 and 2013, a total of 176 patients with a diag-
nosis of Turner syndrome, born between 1960 and 2013, were
seen at the Royal Hospital for Sick Children in Glasgow. Four
of the 176 girls were excluded because of insufficient infor-
mation, which included no available karyotype in three.
Diagnosis was by amniocentesis in 10 (5.8%), during the
newborn period and later infancy in 62 (36%), from 1 to <
5 years in 15 (8.7%), between 5 and 10 years in 33 (19.1%),
from 10 to 15 years in 43 (25%), 15–20 years in 6 (3.4%), >
20 years in one and unknown in two. Three patients had died
during the study period (two cardiac deaths and one malig-
nancy). Fifty cardiac anomalies were present in 33 (19.2%)
patients comprising bicuspid aortic valve (22), aortic coarcta-
tion (14), aortic valve stenosis (5), anomalous venous drain-
age (4), atrial septal defect (2), aberrant systemic veins (2) and
hypoplastic left heart (1).
Renal anomalies were identified in 22 (12.8%) including
13 horseshoe kidneys. A history of middle ear disease was
documented in 94 (54.6%) while immune diseases included
hypothyroidism in 11 (6.4%), type 1 diabetes in only one girl,
inflammatory bowel disease in 3 (1.7%), coeliac disease in 3
(1.7%), scalp psoriasis in 6 (3.4%) and eczema in 5 (2.9%).
Patient and parental height data (see Table 1)
Information on the 172 girls according to parental height mea-
surement (both, one or neither) is shown in Table 1. Accurate
height measurement at diagnosis and beyond the first year of
life was available in 150 of these girls. Measured heights for
both parents were found for 94 girls (see Table 1). One of
these girls was excluded from analysis because of an unusu-
ally short height (− 5.58 SDS) recorded at the late age of
18.6 years and another because no height was available be-
yond the first year, leaving 92 girls. In 37 girls, only one parent
had been measured, attributable to no contact with the father
(8); parental illness (1); parent deceased (1); father never at
clinic (2) and no obvious reason (25). Nomeasured height was
available from either parent in 41 girls, attributable to the child
being fostered/adopted (3); no contact with parents (3); neither
parent at initial clinic visit and not measured subsequently (3)
and no obvious reason (32).
Girls in whom both parents had been measured tended to
have been born more recently, diagnosed at a younger age and
to be less short than girls in whom only one or neither parent
had been measured. However, the only statistically significant
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differences found were in current age of the girls with mea-
sured parents (see Table 1).
Sensitivity of Ht SDS < 2 SDS in girls with Turner
syndrome (whole cohort)
Thirty (17.4%) of the 172 girls were not actually short (Ht
SDS < − 2) at first measurement, giving a sensitivity of
82.6% for crude short stature screening. Median (range) Ht
SDS in the 30 girls with Ht SDS ≥ − 2 was − 1.47 (− 2.00 to +
1.79). These girls were significantly younger at first measure-
ment, median age 3.01 years compared with 8.56 years in the
girls with Ht SDS < − 2 SDS (p = 0.01).
Sensitivity of birthweight SDS < − 2, − 1.5 and − 1 in girls
with Turner syndrome (whole cohort)
Data on birthweight were available in 136 of the 172 girls
while gestation was available in 139. Median birthweight
SDS was below average at − 0.91. After excluding one pre-
term girl with generalised oedema at birth who weighed
3400 g at 34 weeks’ gestation (BW SDS + 3.72), the median
(range) birthweight for all girls was 2805 (690 to 4060 g (be-
tween − 3.6 and + 2.27 SDS). Fifteen girls had birthweight
below − 2 SDS, 36 below − 1.5 SDS and 65 below − 1 SDS,
giving sensitivities of 11, 26.7 and 48% for these cut-offs.
Thirty-seven (27.4%) girls had birthweight between − 1 and
0 SDS, 24 (17.8%) between 0 and + 1 SDS; and only 9 (6.7%)
above 1 SDS.
Growth data on 92 girls in whom initial accurate height
measurement after the age of 1 year and measured
parental heights were available (Fig. 1, Tables 2 and 3)
Mean± SD/median (range) age at first accurate measurement
was 7.68 ± 4.64/1.31–29.7 years. All height data were nor-
mally distributed. As shown in Fig. 2, mean initial height SDS
in the patients was significantly lower than maternal, paternal,
and MPH SDS (p < 0.001, one-way ANOVA). Mean ± SD
patients’ height SDS was also significantly lower than the
LTR SDS: − 2.63 ± 0.94 vs − 1.77 ± 0.81 (p < 0.001, one-way
ANOVA).
In addition to the 92 girls in whom accurate height and mea-
sured parental height in both parents were available, accurate
initial height was available in 31 girls with only one parent mea-
sured (the mother in all but one case) and 15 girls in whom both
parental heights were reported. The difference between LTR and
Ht SDS for the 92 girls with both parents measured was (− 1.77)
− (− 2.67) = 0.9; for the 31 girls in whom only one parent was
measured the difference was (− 1.92)− (− 2.47) = 0.56; and for
Table 1 Demographic and descriptive information on 172 patients with
TS seen at the Royal Hospital for Sick Children in Glasgow between
1989 and 2013 in which data were collected up to 31 December 2014.
Current age of girls in whom neither parent had been measured was
significantly older than for girls in whom either one or both parents had
been measured
All girls [n 172] Both parents measured [n 94] Only one parent measured [n 37] Neither parent measured [n 41]
Age on 1.1.15 (years)
Mean ± SD 27.27 ± 9.97 24.93 ± 9.12* 25.77 ± 8.11** 34.01 ± 10.53*
Median (range) 27.94 (4.34–55.24) 25.90 (4.73–44.02) 26.82 (9.99–39.61) 35.10 (4.34–55.24)
Age at initial height measurement (years)
Mean ± SD 7.68 ± 4.64 7.05 ± 4.05 10.26 ± 5.85 8.53 ± 6.55
Median (range) 7.69 (1.31–29.68) 7.2 (1.31–18.5) 11.39 (2.67–15.60) 6.65 (1.39–29.68)
Height SDS at initial measurement
Mean ± SD −2.70 ± 1.07 (n 146) − 2.63 ± 0.94 (n 92§) − 2.67 ± 1.26 (n 36) − 2.92 ± 0.90 (n 19)
Median (range) [n = 172] − 2.69 (−6.30† to +1.79) − 2.62 (− 4.71 to − 0.32) − 2.71 (1.79 to − 6.30†) − 2.95 (− 1.30 to − 4.88)
Birthweight (grams) 2805 (690–4060) 2800 (690–4060) 3010 (1540–3860) 2800 (1660–3660)
Median (range) [n] [n 136] [n 78] [n 31] [n 27]
Gestation (weeks) 40 (27–44) 39 (27–42) 40 (33–44) 40 (32–41)
Median (range) [n] [n 139] [n 79] [n 32] [n 28]
Karyotype [n] [n 172] [n 94] [n 37] [n 41]
45,X 69 34 16 19
45,X/46XiXq 29 17 5 7
45,X/46,XY 9 6 3 0
45,X/46,XX 9 5 3 1
45,X/47,XXX 11 7 4 0
45,X/46,XrX 14 7 3 4
46,XiXq 6 5 1 0
Other 23 13 2 8
Tested elsewhere 2 0 0 2
*p = 0.0001, **p = < 0.001
†Denotes girl with spina bifida and Turner syndrome in whom Ht SDS was − 6.30
§Denotes 2 girls excluded from height analysis owing to unusually short height (− 5.58 SDS) aged 18.6 years in one; no height available beyond the first
year in the other
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Fig. 2 Height chart for Turner
syndrome showing the growth
pattern of a girl (asterisk in
Table 3) in whom height fell
within the mid-parental target
range and general population at
first accurate measurement. She
then demonstrated decreased
height velocity leading to short
stature by 3.8 years and growth
hormone treatment was started
thereafter. (Figure is reproduced
with kind permission from
Castlemead Publications,
Hertford, UK)
Fig. 1 Box and whisker plot of
height standard deviation score
(Ht SDS) for first accurate
measurement in 92 girls with
Turner syndrome (P), and the Ht
SDS for their mothers (M), fathers
(F), mid-parental height (MPH)
and lower end of target range
(LTR). *p = < 0.001 using one-
way ANOVA
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the 15 girls in whom both parental heights were reported the
difference was (− 1.91) − (− 2.83) = 0.92. None of these differ-
ences achieved statistical significance.
Table 2 shows that in the 92 girls where measured height
was available for both parents, Ht SDS at first accurate mea-
surement was below LTR SDS in 78 (sensitivity 85%) while
14 (15%) girls had Ht SDS ≥ LTR SDS. Eleven of 38 girls
aged < 5 years had Ht SDS ≥ LTR SDS (71% sensitivity).
Median (range) age at first measurement in these 11 girls
was 3.0 (1.8–4.99) years, five of the girls being under 3 years
of age. Only three girls in the 5–10 year range had Ht SDS >
LTR SDS (90.3% sensitivity) and none aged > 10 years
(100% sensitivity).
Table 3 gives details on the 14 girls with Ht SDS > LTR
SDS. More than half of the 14 girls had 45,X monosomy (n =
8). Five had karyotypes known to be associated with a milder
phenotype so that 2 of the 5 girls with 45,X/46,XX and 3 of
the 7 girls with 45,X/47,XXX had initial Ht SDS > LTR SDS.
Only one of these five girls was actually short, i.e. < − 2SD.
Discussion
We have examined a group of girls with Turner syn-
drome from the West of Scotland in order to audit the
frequency with which parental height had been mea-
sured and also to test the sensitivity of height at first
measurement in the girls in relation to their measured
parental heights.
In this unselected cohort, the prevalence of cardiac and
renal disease is lower, albeit of similar order, while the
54.6% prevalence of middle ear disease is similar to that pre-
viously reported [13], indicating that our patients are reason-
ably representative of Turner syndrome. An unexpected find-
ing in the course of this study is a relatively high prevalence of
scalp psoriasis (3.4%), an observation which merits further
study.
Table 3 Karyotype, height status
and birthweight (BW) data in 14
girls with Turner syndrome
whose initial accurate height
measurement > 1 year of age fell
above the lower end of the
parental target range (LTR) height
SDS
Karyotype Age at first
accurate measurement (years)
Ht SDS LTR SDS BW SDS Comment
45,X 1.78 − 1.52 − 2.45 − 0.02 Father short
(Ht SDS − 2.09)
45,X 2.40 − 1.42 − 2.71 N/A
45,X 2.46 − 0.62 − 1.25 0.09
45,X/47,XXX 2.51 − 0.60 − 1.88 N/A
45,X 2.69 − 0.57 − 1.43 N/A
45,X/47,XXX 3.01 − 0.75 − 0.83 − 2.74
45,X 3.23 − 1.25 − 1.31 1.08
45,X 3.27 − 2.15 − 2.78 1.98 Father short
(Ht SDS − 2.2)
45,X/47,XXX 4.24 − 1.19 − 1.73 − 1.76
45,X 4.93 − 2.15 − 2.66 − 1.30
45,X/46,XX 4.99 − 0.32 − 1.72 N/A
45,X/46,Xr(X) 7.20 − 1.05 − 1.46 N/A
45,X/46,XX 9.08 − 2.75 − 2.85 N/A
45,X 9.10 − 2.02 − 2.16 − 1.34
Data are ranked according to age at initial height measurement
N/A not available
Table 2 Height standard deviation score (Ht SDS) of 92 girls with
Turner syndrome in whom both parental heights were measured,
grouped according to age at first measurement and to whether height
standard deviation score (Ht SDS) was < or ≥ the lower end of parental
target range SDS (LTR SDS)
Age at first accurate height measurement
1–5 years
(n = 38)
5.1–10 years
(n = 30)
10.1–16 years
(n = 24)
1–16 years
(n = 92)
< LTR SDS
(n) 28 27 21 76
(%) 74 90 88 83
≥ LTR SDS
(n) 10 3 3 16
(%) 26 10 13 17
Ht SDS < − 2
(n) 27 25 22 74
(%) 71 83 92 80
Ht SDS ≥ − 2
(n) 11 5 2 18
(%) 29 17 8 20
Eur J Pediatr
Both parents had been measured in 94 of the 172 girls—
only just over half. Those with measured parental heights
were not different from girls in whom only one or neither
parent had been measured except in age—the girls with no
measured parental height were significantly older. We infer
that girls born earlier, e.g. in the 1970s and before, would be
more likely not to have both parents measured. However, it
was common, even in recently diagnosed patients, for one
parent (usually the father) not to be measured. Parental height
is usually measured at the initial visit to the clinic and if only
one parent is present the other parent may not be measured
subsequently, particularly when the diagnosis of Turner syn-
drome has already been made. However, measured parental
height is not only of value in diagnosis but also for determin-
ing the target height for the girl with or without growth hor-
mone treatment.
Analysis of the difference between parental LTR SDS and
girls’Ht SDS in girls with both parental heights measured, one
parental height measured, and both parental heights reported
is interesting with differences of 0.9, 0.56, and 0.92 for the
three groups. We interpret this as showing that when the fa-
thers’ report their height, they overestimate it, leading to a
reduction in the LTR/Ht SDS difference (0.56 vs 0.9). We also
speculate that when the heights of both parents are reported,
the mothers tend to underestimate their height while the fa-
thers tend to overestimate height as previously reported [2] so
that the errors cancel one another out. Clearly, it is not desir-
able to subject girls with a growth disorder such as Turner’s
syndrome to the vagaries of reported height.
The data from this study raise wider questions
concerning the adequacy of clinical assessment in chil-
dren with growth problems in general, and not just
those with Turner syndrome. If only just over half the
parents of Turner girls have been measured in a tertiary
referral clinic, it is likely that this figure is similar for
other disorders such as hypopituitarism and almost cer-
tainly lower in the general paediatric clinic. Yet, this
study confirms the value of comparing patient height
with parental height, while previous work has shown
the superiority of measured rather than reported parental
height [2]. A more rigorous approach is required to
ensure that both parents are measured in clinic and that
missing heights from the initial visit are secured at a
later stage where possible.
Although there was no documented reason for non-
measurement of one or both parents in 57 girls, a significant
proportion of parental heights will be unavailable at the time
of first measurement due to factors such as separation and
divorce. In a separate study, we have evaluated the feasibility
of obtaining parental heights at the time of birth in small
babies as well as securing accurate length measurement [14].
We would also make the case for measuring not only mothers
antenatally as is standard obstetric practice in the UK but also
their partners, transcribing this information onto the neonatal
growth record as part of good practice in the promotion of
child health.
We should stress that in our study population, short stature
was by no means the key factor in the diagnosis of Turner
syndrome in every patient. On the contrary, the diagnosis
had been made before 1 year in 40% of the girls, and would
have been related to features such as dysmorphism,
lymphoedema and to problems such as aortic coarctation rath-
er than short stature. Thus, the present study is not concerned
with diagnosis in Turner syndrome per se. Rather, it consti-
tutes an exercise in determining how many of the girls in our
clinic were and were not below their parental height target
range at the first age of accurate measurement, and includes
those who had been already been diagnosed through features
other than short stature. On the other hand, some girls were
diagnosed late with short stature and delayed puberty, the
prevalence in our study group being of similar order to the
study of Massa et al. [7] who reported diagnosis aged >
12 years in 54 (22%) of 242 girls compared with nearly
30% aged > 10 years in ours.
It should also be noted that even when the diagnosis of
Turner syndrome has been made, parental height status is still
relevant in setting a standard for height which the family can
realistically expect and which the clinician should aim to
achieve, i.e. the lower end of the target range.
This study confirms the limited sensitivity of both short
stature screening and birthweight analysis in the diagnosis of
Turner syndrome. The sensitivity of detecting girls who were
< − 2 SDS in height at first measurement was 82.1%, indicat-
ing that screening girls who are actually short will miss nearly
20%. Moreover, although birthweight was below average in
102 of 136 girls (75%), only half had birthweight < − 1 SDS,
and only 11% below − 2 SDS, these cut-offs being insuffi-
ciently sensitive or specific to be of practical use. Our findings
are in keeping with the work of Hagman et al. [5] and show
that although a degree of intrauterine growth restriction is
common in Turner syndrome, this feature of the condition is
not helpful in diagnosis. Fifteen girls had birthweight below −
2 SDS, 36 below − 1.5 SDS and 65 below − 1 SDS, giving
sensitivities of 11, 26.7 and 48% for these cut-offs. Thirty-
seven (27.4%) girls had birthweight between − 1 and 0 SDS,
24 (17.8%) between 0 and + 1 SDS; and only 9 (6.7%) above
1 SDS.
The sensitivity of measuring Ht SDS in 92 girls against
parental heights was slightly greater than that obtained using
the general population cut-off of < 2 SDS—83 vs 80%
(Fig. 2)—and similar to the figure of 82.6% obtained for de-
tecting short stature in the whole cohort. However, the former
method is much more specific since it takes account of paren-
tal heights and is hence less likely to miss girls with tall par-
ents. When the sensitivity of Ht SDS vs LTR SDS was exam-
ined in relation to age group it was found that 11 of 14 girls
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whowere within the parental target range SDSwere below the
age of 5 years, with only 3 aged 5–10 years and none above
10 years (see Table 2). This finding is in keeping with the
documented growth pattern shown by Turner-specific growth
charts (see Fig. 2) which shows that growth velocity is typi-
cally low-normal for the first 3–4 years, with height falling
away from the 3rd centile thereafter. Individuals with 45,X/
46,XX genotype are known to be more mildly affected [17] as
are those with the 45,X/47,XXX genotype [1] so that these
girls will tend to be within the upper half of the Turner-specific
charts and indeed may remain within the normal population
range. We advise monitoring growth in girls with Turner syn-
drome using both condition-specific and population-based
growth charts. Thus, while our study confirms the integral
place of parental height measurement in the assessment of
girls with Turner syndrome, it is evident that this aspect of
auxology should not be over-relied on, particularly in the
young patient. Also, Wright and Cheetham have pointed out
the limitations of the mid-parental height model, especially
when parents are particularly tall or short, although their study
relied on reported rather than measured parental height [19].
The criteria described by Saari et al. have the advantage of
taking height velocity as well as height status and parental
heights into account [12]. However this model is not readily
applicable to the initial presentation unless accurate previous
measurements are available and may not always be practical
in a busy clinic.
In conclusion, parental height measurement is a sen-
sitive and valuable adjunct to growth assessment in chil-
dren with growth problems, including but not confined
to children with Turner syndrome. Applying the mid-
parental height and target range to the child’s growth
assessment is not a fail-safe system, particularly in pre-
school children, and should be regarded as only one
aspect of good clinical practice. Finally, there is a clear
need to measure parental height more rigorously in our
clinic, and this is likely to be the case in other centres.
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